Screener
ClearPoint Neuro CLPT Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| General and administrative expenses | 4,997 | 4,082 |
| Operating loss | (8,478) | (6,163) |
| Other income (expense): | ||
| Other (expense) income, net | (35) | 4 |
| Interest income | 351 | 151 |
| Interest expense | (1,382) | — |
| Net loss before income taxes | (9,544) | (6,008) |
| Income tax expense | 8 | 18 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's other income (expense)?
- ClearPoint Neuro (CLPT) reported other income (expense) of -$35K in Q1 2026.
- How has ClearPoint Neuro's other income (expense) changed year-over-year?
- ClearPoint Neuro's other income (expense) decreased by 975.0% year-over-year, from $4K to -$35K.
- What is the long-term trend for ClearPoint Neuro's other income (expense)?
- Over 4 years (2021 to 2025), ClearPoint Neuro's other income (expense) has grown at a 23.9% compound annual growth rate (CAGR), from -$62K to -$146K.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about ClearPoint Neuro's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude